
View larger version (115K):
[in a new window]
|
Fig. 5. FGF8b activates more molecular pathways than FGF8a, FGF17b and FGF18. (A-D)
1 µg/µl pMiw-Fgf8a induces Fgf8 (C), but does not
induce Gbx2 (B) or Spry1 (D), or repress Otx2 (A).
(E-H) 1 µg/µl pMiw-Fgf8b induces Gbx2 (F),
Fgf8 (G) and Spry1 (H) and represses Otx2 (E).
(I-L) 1 µg/µl pMiw-Fgf17b fails to induce Gbx2 (J),
Fgf8 (K) or Spry1 (L), or to repress Otx2 (I).
(M-P) 1 µg/µl pMiw-Fgf18 fails to induce Gbx2 (N),
Fgf8 (O) or Spry1 (P), or to repress Otx2 (M).
(Q-T) 1 µg/µl pMiw-caFGFR2 induces Gbx2 (R),
Fgf8 (S) and Spry1 (T) in scattered cells. Otx2 is
repressed on the electroporated side but scattered Otx2-expressing
cells still exist (Q). In all panels, coronal or near coronal sections are
shown with the anterior end towards the right. The broken lines indicate the
midline with the electroporated side above the line and the control side
below. In all panels, the red arrowheads indicate ectopic gene expression on
the electroporated side and the green arrowheads indicate endogenous
expression on the control side except for E and Q where the red arrowheads
indicate the electroporated side where Otx2 expression is repressed
(completely in E and incompletely in Q). Insets in A,C,E,G,I,M,Q show
expression of the mouse or human genes electroporated into the right side of
the brain.
|